eye-on-india

Reporter's Take | Sun Pharma stock dives to 6-month low amid cloud over corporate governance

M Saraswathy gets in conversation with Moneycontrol's Viswanath Pilla to discuss the implications of Macquarie note, Sun Pharma's response to the accusations, the future of the company and much more.

first published: Nov 29, 2018 04:33 pm

LATEST VIDEOS

Watch More →

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347